Brief: Zynex announces first enrollments in Apheresis donation clinical trial with second generation fluid monitoring system
15/08/2022 14:18
Aug 15 (Reuters) - Zynex Inc ZYXI.O :
* ZYNEX ANNOUNCES FIRST ENROLLMENTS IN APHERESIS DONATION
CLINICAL
TRIAL WITH SECOND GENERATION FLUID MONITORING SYSTEM
* ZYNEX INC - STUDY IS EXPECTED TO COMPLETE ENROLLMENTS IN
Q4 OF
2022
Source text for Eikon: ID:nPn6RKcdda
Further company coverage: ZYXI.O
Recent news on Zynex
See all newsBrief: Court Confirms Zynex Plan Of Reorganization On March 19, 2026 - SEC Filing
Brief: Zynex Inc Says SEC Concluded Investigation Into Zynex, No Enforcement Action Planned
Brief: Zynex Inc Resolves Federal Investigation Into Business Practices
Brief: Zynex Secures $22.3 Million Dip Facility From Lenders And CEO
Brief: Zynex Financial Restructuring Puts Company On Path To Long-Term Success